Heterocyclic Compounds: News and Research on Adenosine

MeSH tree: D03.633.100.759.590.138

Improving treatment for hairy cell leukemia

Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.

Ceritinib offers a promising target for cancer immunotherapy

Many tumor cells mist themselves with a protective perfume that disables the immune system. But a drug already approved for other purposes can apparently render this weapon harmless. This is shown in a study by the University ...

page 5 from 6